Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDY391 in Moderate to Severe Psoriatic Arthritis
NCT07801495Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of DDY391 in psoriatic arthritis (PsA), sponsored by Novartis. Started Oct 2026; status: recruiting.
02
Drugs
DDY391
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07801495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07801495.